Synthesis, characterization, and anticancer evaluation of N-(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.

Authors

Publication Details

Journal
Figshare
Published
2026-11-19
DOI
https://doi.org/10.6084/m9.figshare.35060796
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis, characterization, and anticancer evaluation of N-(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

Kavati Shireesha, Kumara Swamy Jella, Shaganti Venkatesh
Figshare
Heterocyclic Compound Synthesis and Bioactivity
article

Synthesis, characterization, and anticancer evaluation of N-(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds

Kavati Shireesha, Kumara Swamy Jella, Shaganti Venkatesh
article en

Abstract

The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.

Figshare
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon